Skip to main content
SpringerLink
Log in

Supportive Maßnahmen beim Tumorpatienten

  • Chapter
Book cover Uroonkologie

Zusammenfassung

Supportive Maßnahmen beim Patienten mit maligner Tumorerkrankung umfassen eine suffiziente Schmerztherapie, die Substitution von Blut und Blutprodukten, ergänzende Maßnahmen zur Chemotherapie, um die Verträglichkeit zu verbessern, sowie eine ausreichende Ernährung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Society of Clinical Oncology (1994) Recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. Clin Oncol 12:2471–2508

    Google Scholar 

  • Balkwill F, Burke F, Talbot D et al. (1987) Evidence for tumour necrosis factor/cachectin production in cancer. Lancet II: 1229–1232

    Google Scholar 

  • Berdel WE, Oberberg D, Reufi B, Thiel E (1991) Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro. Ann Hematol 63:5–8

    Article  PubMed  CAS  Google Scholar 

  • Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328–340

    PubMed  CAS  Google Scholar 

  • Bokemeyer C, Schmoll HJ (1993) Treatment of advanced germ cell tumours by dose intensified chemotherapy with haematopoietic growth factors or peripheral blood stem cells (PBSC). Eur Urol 23:223–229

    PubMed  CAS  Google Scholar 

  • Cascinu S, Fedeli A, del Ferro E, Fedeli SL, Catalano G (1994) Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized double-blind trial with placebo. Clin Oncol 12:1058–1062

    CAS  Google Scholar 

  • Clamon GH, Feld R, Evans WK et al. (1985) Effect of adjuvant central IV hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trial. Cancer Treat Rep 69:167–177

    PubMed  CAS  Google Scholar 

  • Dale DC, Guerry D, Wewerka IV, Bull JM, Chusid MJ (1979) Chronic neutropenia. Medicine 58:128–144

    Article  PubMed  CAS  Google Scholar 

  • Deisseroth A, Wallerstein R (1989) Use of blood and blood products. In: DeVita VT Jr, Hellmann S, Rosenberg SA (eds) Cancer principles and practice of oncology, 3rd edn. Lippincott, Philadelphia, pp 2045–2059

    Google Scholar 

  • Denzlinger C, Holler E, Reisbach G, Hiller E, Wimanns WK (1994) Granulocyte colony-stimulating factor inhibits the endogenous leukotriene production in tumour patients. Br J Haematol 86:881–882

    Article  PubMed  CAS  Google Scholar 

  • DeWys WD, Begg C, Lavin PT et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491–497

    Article  PubMed  CAS  Google Scholar 

  • Doenicke A (1987) Medikamentöse Schmerztherapie beim inkurablen Prostatakarzinom. Aktuelle Urol 18:210–214

    Article  Google Scholar 

  • Drew JW, Winston G, Gale RP (1982) Therapeutic granulocyte transfusions for documented infections. Ann Intern Med 97:509–515

    Google Scholar 

  • Emminger W, Emminger Schmidmeier W, Peters C et al. (1990) Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rh-GM-CSF) treatment of a patient in a continuous febrile state. Blut 61:219–221

    Article  PubMed  CAS  Google Scholar 

  • Evans WK, Nixon DW, Daly JM et al. (1987) A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol 5:113–124

    PubMed  CAS  Google Scholar 

  • Finkelstein DM, Ettinger DS, Ruckdeschel JC (1986) Long-term survivors in metastatic non-small-cell lung cancer: an Eastern cooperative oncology group study. J Clin Oncol 4:702–709

    PubMed  CAS  Google Scholar 

  • Gabrilove JL, Jakubowski A, Scher H et al. (1988) Effect of granulocyte colonystimulating factor on neutropenia and associated morbitity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414–1422

    Article  PubMed  CAS  Google Scholar 

  • Gaydos LA, Freireich EJ, Mantel N (1962) The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 266:905–909

    Article  PubMed  CAS  Google Scholar 

  • Harker LA, Slichter SJ (1972) The bleeding time as screening test for evaluation of platelet function. N Engl J Med 287:155–159

    Article  PubMed  CAS  Google Scholar 

  • Herrmann F, Ganser A, Lindemann A et al. (1990) Stimulation of-granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administration. J Biol Resp Mod 9:475–479

    CAS  Google Scholar 

  • Hersman J, Meyers JD, Thomas ED et al. (1982) The effect of granulocyte transfusion upon the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med 96:149–152

    PubMed  CAS  Google Scholar 

  • Hitomi K, Fujita K, Sasaki R et al. (1988) Erythropoietin receptor of a human leukemic cell line with erythroid characteristics. Biochem Biophys Res Comm 154:902–909

    Article  PubMed  CAS  Google Scholar 

  • Hollingshead LM, Goa KL (1991) Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of ist pharmacological properties and prospective role in neutropenic conditions. Drugs 42:300–330

    Article  PubMed  CAS  Google Scholar 

  • Hughes WT, Armstrong D, Bodey GP et al. (1990) Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 161:381–396

    Article  PubMed  CAS  Google Scholar 

  • Issel BF, Valdivieso M, Zaren H (1978) Protection against chemotherapy toxicity by i.v. hyperalimentation. Cancer Treat Rep 59:437

    Google Scholar 

  • Jordan WM, Valdivieso M, Frankman C (1981) Treatment of advanced adenocarcinoma of the lung with ftorofur, doxorubicin, cyclophosphamide, and cis-platinum and intensive i.v. hyperalimentation. Cancer Treat Rep 64:197

    Google Scholar 

  • Logothetis CJ, Dexeus FH, Sella A et al. (1990) Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte macrophage colony-stimulating factor. J Natl Cancer Inst 82:667–672

    Article  PubMed  CAS  Google Scholar 

  • Ludwig H, Fritz E, Kotzmann H et al. (1990) Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322:1693–1699

    Article  PubMed  CAS  Google Scholar 

  • Meryman HT (1989) Transfusion-induced alloimmunization and immunosuppression and the effects of leukozyte depletion. Transfusion Med Rev 3:180–193

    Article  CAS  Google Scholar 

  • Metcalf D (1990) The colony stimulating factors. Discovery, development, and clinical applications. Cancer 65:2185–2195

    Article  PubMed  CAS  Google Scholar 

  • Müller JM, Brenner U, Dienst C, Pichlmaier H (1982) Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet 1:68–71

    Article  PubMed  Google Scholar 

  • Mundt D, Berger MR, Bode G (1992) Effect of recombinant human erythropoietin in the growth of human tumor cell lines in vitro. Drug Res 42:92–95

    CAS  Google Scholar 

  • Newland A C. (1994) Cytokines-A better route to platelet recovery. European Society for Medical Oncology, Lisbon, Friday 18th November 1994

    Google Scholar 

  • Okuno Y, Takahashi T, Suzuki A et al. (1990) Expression of the erythropoeitin receptor on a human myeloma cell line. Biochem Biophys Res Comm 170:1128–1134

    Article  PubMed  CAS  Google Scholar 

  • Pecherstorfer M, Schmoranzer F, Vesely M et al. (1990) Erythropoietin beim multiplen Myelom. Dtsch Med Wochenschr 115:1096–1099

    Article  PubMed  CAS  Google Scholar 

  • Pizzo PA, Meyers J (1989) Infections in the cancer patient. In: De Vita VT Jr, Hellmann S, Rosenberg SA (eds) Cancer principles and practice of oncology, 3rd edn. Lippincott, Philadelphia, pp 2088–2133

    Google Scholar 

  • Samuels ML, Selig R, Ogden S (1981) IV hyperalimentation and chemotherapy for stage III testicular cancer: a randomized study. Cancer Treat Rep 65:615

    PubMed  CAS  Google Scholar 

  • Serrou B, Cupissol D, Plagne R (1981) Parenteral intravenous nutrition (PNH) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma. Cancer Treat Rep 65 [Suppl 5]: 151

    PubMed  Google Scholar 

  • Shike M, Brennan MF (1989) Supportive care of the cancer patient. In: De Vita VT Jr, Hellmann S, Rosenberg SA (eds) Cancer principles and practice of oncology, 3rd edn. Lippincott, Philadelphia, pp 2029–2044

    Google Scholar 

  • Stein AC, Jones TC (1992) The side-effect profile of GM-CSF. Infection 20 [Suppl 21:124–127

    Google Scholar 

  • Walker RH (1987) Special report: transfusion risks. Am J Clin Pathol 88:374–378

    PubMed  CAS  Google Scholar 

  • Warren S (1932) The immediate causes of death in cancer. Am J Med Sci 184: 610

    Article  Google Scholar 

  • Weissmann DE, Dahl JL (1990) Attitudes about cancer pain: a survey of Wisconsin’s first year medical students. J Pain Symptom Manage 5:345–349

    Article  Google Scholar 

  • World Health Organization (1986) Cancer pain relief. WHO, Geneva

    Google Scholar 

  • Zimmermann M (1981) Physiologische Mechanismen von Schmerz und Schmerztherapie. Triangle 20:7–18

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. Wirth
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Urologische Klinik und Poliklinik, Medizinische Einrichtungen der Universität-GHS Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Herbert Rübben (Direktor der Urologischen Klinik und Poliklinik) (Direktor der Urologischen Klinik und Poliklinik)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wirth, M. (1997). Supportive Maßnahmen beim Tumorpatienten. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10731-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10731-7_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10732-4

  • Online ISBN: 978-3-662-10731-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation